They found that patients with mutations in the head motor exons were more likely to experience severe thrombocytopenia, a higher number of giant platelets, increased bleeding tendencies, and a greater risk of kidney disease, cataracts, and hearing loss compared to those with mutations in the tail domain of NMMHC-IIA. Here, MYH9 is linked to kidney disorder.